Genetic Counseling for Prostate Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Prostate Cancer+8 MoreGenetic Counseling - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial study is trying to find ways to make the VERDI model more accessible to a more diverse group of people who are at risk for hereditary cancers.

Eligible Conditions
  • Prostate Cancer
  • Genetic Testing
  • Melanoma
  • Ovarian Cancer
  • Breast Cancer
  • Pancreatic Cancer
  • Kidney Cancer
  • Sarcoma
  • Colorectal Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 3 Weeks

3 Weeks
Video Education Acceptability (Qualitative Interview Study)

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

QUALITATIVE ASSESSMENT
1 of 3
RCT-VERDI
1 of 3
RCT-Genetic Counseling
1 of 3

Experimental Treatment

1020 Total Participants · 3 Treatment Groups

Primary Treatment: Genetic Counseling · No Placebo Group · N/A

QUALITATIVE ASSESSMENT
Behavioral
Experimental Group · 1 Intervention: Video Education · Intervention Types: Behavioral
RCT-VERDI
Behavioral
Experimental Group · 1 Intervention: Video Education · Intervention Types: Behavioral
RCT-Genetic Counseling
Behavioral
Experimental Group · 1 Intervention: Genetic Counseling · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Genetic Counseling
2008
Completed Phase 3
~4940
Video Education
2017
N/A
~200

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 weeks

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,071 Previous Clinical Trials
41,127,835 Total Patients Enrolled
536 Trials studying Prostate Cancer
501,376 Patients Enrolled for Prostate Cancer
Dana-Farber Cancer InstituteLead Sponsor
1,016 Previous Clinical Trials
392,796 Total Patients Enrolled
67 Trials studying Prostate Cancer
15,091 Patients Enrolled for Prostate Cancer
National Human Genome Research Institute (NHGRI)NIH
251 Previous Clinical Trials
277,803 Total Patients Enrolled
4 Trials studying Prostate Cancer
13,240 Patients Enrolled for Prostate Cancer
Huma Q. Rana, MD., MPHPrincipal InvestigatorDana-Farber Cancer Institute

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are able to understand the nature and purpose of the study and are willing to sign a written informed consent document.